ctrl K

AI Score

Unlock

Lexicon Pharmaceuticals I... (LXRX)

AI Score

Unlock

0.46

-0.00 (-0.17%)

At close: Apr 01, 2025, 3:59 PM

0.46

0.08%

After-hours: Apr 01, 2025, 07:59 PM EDT

Lexicon Pharmaceuticals Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	31.08M	1.2M	139K	298K	24M
Cost of Revenue	616K	85K	427K	55.05M	1.93M
Gross Profit	30.46M	1.12M	-288K	-54.75M	22.07M
Operating Income	-197.12M	-171.75M	-100.76M	-87.09M	-178.78M
Interest Income	12.29M	7.73M	1.6M	134K	2.77M
Pretax Income	-200.4M	-177.12M	-101.94M	-87.76M	-58.57M
Net Income	-200.4M	-177.12M	-103.13M	-88.27M	-70.18M
Selling & General & Admin	143.1M	113.98M	48.08M	32.34M	47.23M
Research & Development	84.48M	58.89M	52.82M	55.05M	153.62M
Other Expenses	n/a	n/a	n/a	n/a	1.6M
Operating Expenses	227.58M	172.87M	100.9M	87.39M	200.85M
Interest Expense	15.58M	13.1M	2.78M	802K	14.54M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	228.2M	172.95M	100.9M	87.39M	202.78M
Income Tax	n/a	n/a	1.18M	510K	11.61M
Shares Outstanding (Basic)	320.03M	221.13M	165.73M	145.65M	110.84M
Shares Outstanding (Diluted)	320.03M	221.13M	165.73M	145.65M	110.84M
EPS (Basic)	-0.63	-0.8	-0.62	-0.61	-0.63
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-184.29M	-163.46M	-98.74M	-86.66M	-41.1M
Depreciation & Amortization	534K	554K	427K	292K	2.93M